Opposite expression of securin and γ-H2AX regulates baicalein-induced cancer cell death

Journal of Cellular Biochemistry

Volumn 111, Issue 2, 2010, Pages 274-283

  Jiang, Ren Huei ^a,b   Su, Wen Chi ^a,b   Liu, Huei Fang ^a   Huang, Hou Syun ^a   Chao, Jui I ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

H2AX; AKT; Apoptosis; Baicalein; Cell Viability; Securin

Indexed keywords

BAICALEIN; HISTONE H2AX; PROTEIN KINASE B; SECURIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; WORTMANNIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CELL TYPE; CELL VIABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANTIOXIDANTS; CELL LINE, TUMOR; CELL SURVIVAL; FLAVANONES; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HISTONES; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT;

SCUTELLARIA BAICALENSIS;

EID: 77957276131     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22697     Document Type: Article

References (51)

1. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M, Pintor-Toro JA. 2002. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 32:306-311.
2. Bonham M, Posakony J, Coleman I, Montgomery B, Simon J, Nelson PS. 2005. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res 11:3905-3914. (Pubitemid 40685612)
3. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321. (Pubitemid 28524494)
4. Chao JI, Liu HF. 2006. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells. Mol Pharmacol 69:154-164.
5. Chao JI, Hsu SH, Tsou TC. 2006. Depletion of securin increases arsenite-induced chromosome instability and apoptosis via a p53-independent pathway. Toxicol Sci 90:73-86.
6. Chao JI, Su WC, Liu HF. 2007. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol Cancer Ther 6:3039-3048.
7. Chen CH, Huang LL, Huang CC, Lin CC, Lee Y, Lu FJ. 2000. Baicalein, a novel apoptotic agent for hepatoma cell lines: A potential medicine for hepatoma. Nutr Cancer 38:287-295. (Pubitemid 32762030)
8. Chesnokova V, Kovacs K, Castro AV, Zonis S, Melmed S. 2005. Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. Mol Endocrinol 19:2371-2379.
9. Christopoulou L, Moore JD, Tyler-Smith C. 2003. Over-expression of wildtype Securin leads to aneuploidy in human cells. Cancer Lett 202:213-218. (Pubitemid 37485894)
10. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. 2000. Serine/threonine protein kinases and apoptosis. Exp Cell Res 256:34-41.
11. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241. (Pubitemid 27456390)
12. Di Carlo G, Mascolo N, Izzo AA, Capasso F. 1999. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci 65:337-353.
13. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M, Pintor-Toro JA. 1998. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17:2187-2193.
14. Downward J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262-267.
15. Funabiki H, Yamano H, Kumada K, Nagao K, Hunt T, Yanagida M. 1996. Cut2 proteolysis required for sister-chromatid seperation in fission yeast. Nature 381:438-441.
16. Hamid T, Kakar SS. 2004. PTTG/securin activates expression of p53 and modulates its function. Mol Cancer 3:18.
17. Hamid T, Malik MT, Kakar SS. 2005. Ectopic Expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells. Mol Cancer 4:3.
18. Havsteen B. 1983. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141-1148.
19. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. 1999. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317-1321.
20. Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B, Lengauer C. 2001. Securin is required for chromosomal stability in human cells. Cell 105:445-457.
21. Kakar SS, Jennes L. 1999. Molecular cloning and characterization of the tumor transforming gene (TUTR1): A novel gene in human tumorigenesis. Cytogenet Cell Genet 84:211-216.
22. Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH. 2004. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. J Pediatr Surg 39:516-521.
23. Kim D, Pemberton H, Stratford AL, Buelaert K, Watkinson JC, Lopes V, Franklyn JA, McCabe CJ. 2005. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells. Oncogene 24:4861-4866.
24. Kim DS, Franklyn JA, Smith VE, Stratford AL, Pemberton HN, Warfield A, Watkinson JC, Ishmail T, Wakelam MJ, McCabe CJ. 2007. Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 28:749-759.
25. Kobayashi T, Nakata T, Kuzumaki T. 2002. Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 176:17-23.
26. Kulik G, Klippel A, Weber MJ. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 17:1595-1606.
27. Kuntz S, Wenzel U, Daniel H. 1999. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38:133-142.
28. Kuo PC, Liu HF, Chao JI. 2004. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 279:55875-55885.
29. Lee HZ, Leung HW, Lai MY, Wu CH. 2005. Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25:959-964.
30. Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386:623-627.
31. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
32. Ma Z, Otsuyama K, Liu S, Abroun S, Ishikawa H, Tsuyama N, Obata M, Li FJ, Zheng X, Maki Y, Miyamoto K, Kawano MM. 2005. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood 105:3312-3318.
33. Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L, Ruggeri A, Conte R, Cocco L. 2003. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 17:1794-1805.
34. Miocinovic R, McCabe NP, Keck RW, Jankun J, Hampton JA, Selman SH. 2005. In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol 26:241-246.
35. Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, Tsuruo T. 2003. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 63:824-830.
36. Nagao K, Adachi Y, Yanagida M. 2004. Separase-mediated cleavage of cohesin at interphase is required for DNA repair. Nature 430:1044-1048.
37. Nasmyth K. 2001. Disseminating the genome: Joining, resolving, and separating sister chromatids during mitosis and meiosis. Annu Rev Genet 35:673-745.
38. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10:886-895.
39. Pei L, Melmed S. 1997. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441.
40. Pidgeon GP, Kandouz M, Meram A, Honn KV. 2002. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 62:2721-2727.
41. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD. 1996. Flavonoids activate wild-type p53. Oncogene 13:1605-1614.
42. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. 2002. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12:162-169.
43. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. 2000. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275:9390-9395.
44. Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M, Pintor-Toro JA. 1999. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18:5473-5476.
45. Stemmann O, Zou H, Gerber SA, Gygi SP, Kirschner MW. 2001. Dual inhibition of sister chromatid separation at metaphase. Cell 107:715-726.
46. Wang Z, Yu R, Melmed S. 2001. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol 15:1870-1879.
47. Yamamoto A, Guacci V, Koshland D. 1996. Pds1p, an inhibitor of anaphase in budding yeast, plays a critical role in the APC and checkpoint pathway(s). J Cell Biol 133:99-110.
48. Yanagida M. 2000. Cell cycle mechanisms of sister chromatid separation; roles of Cut1/separin and Cut2/securin. Genes Cells 5:1-8.
49. Yu R, Ren SG, Horwitz GA, Wang Z, Melmed S. 2000. Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: Evidence from live cell imaging. Mol Endocrinol 14:1137-1146.
50. Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD, Melmed S. 1999. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13:156-166.
51. Zou H, McGarry TJ, Bernal T, Kirschner MW. 1999. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285:418-422.